Skip to main content
Erschienen in: Osteoporosis International 12/2019

19.10.2019 | Editorial

Bisphosphonates and lower mortality risk: when it sounds to be good to be true …

verfasst von: W. D. Leslie

Erschienen in: Osteoporosis International | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Excerpt

Osteoporosis is a potentially lethal condition. Some of this excess mortality is attributable to the time-dependent increase in death that occurs in the aftermath of a fracture, particularly a hip fracture [1]. However, the factors that contribute to developing osteoporosis in the first place, including lifestyle (malnutrition, smoking, alcoholism) and medical comorbidities (too numerous to list) also increase mortality risk independent of any effect on fracture [2]. Indeed, mortality is highest in the first year after the fracture event and rapidly wanes with time, suggesting a decreasing proportion of deaths causally related to the fracture [35]. This complex interplay between fracture and death is explicitly modeled in the fracture risk assessment tool (FRAX) [6]. Indeed, when fracture probability is estimated in the presence of competing mortality the exponential age-dependent increase in fracture risk is actually counteracted, reaching an inflection point around age 80 years, with a subsequent downturn [7]. …
Literatur
1.
Zurück zum Zitat Schousboe JT (2017) Mortality after osteoporotic fractures: what proportion is caused by fracture and is preventable? J Bone Miner Res 32(9):1783–1788CrossRef Schousboe JT (2017) Mortality after osteoporotic fractures: what proportion is caused by fracture and is preventable? J Bone Miner Res 32(9):1783–1788CrossRef
2.
Zurück zum Zitat Teng GG, Curtis JR, Saag KG (2008) Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol 26(5 Suppl 51):S125–S137PubMedPubMedCentral Teng GG, Curtis JR, Saag KG (2008) Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol 26(5 Suppl 51):S125–S137PubMedPubMedCentral
3.
Zurück zum Zitat Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15(2):108–112CrossRef Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B (2004) Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int 15(2):108–112CrossRef
4.
Zurück zum Zitat Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15(1):38–42CrossRef Johnell O, Kanis JA, Oden A, Sernbo I, Redlund-Johnell I, Petterson C et al (2004) Mortality after osteoporotic fractures. Osteoporos Int 15(1):38–42CrossRef
5.
Zurück zum Zitat Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22(9):2439–2448CrossRef Morin S, Lix LM, Azimaee M, Metge C, Caetano P, Leslie WD (2011) Mortality rates after incident non-traumatic fractures in older men and women. Osteoporos Int 22(9):2439–2448CrossRef
6.
Zurück zum Zitat Kanis JA, Johansson H, Oden A, McCloskey EV (2009) Assessment of fracture risk. Eur J Radiol 71(3):392–397CrossRef Kanis JA, Johansson H, Oden A, McCloskey EV (2009) Assessment of fracture risk. Eur J Radiol 71(3):392–397CrossRef
7.
Zurück zum Zitat Kanis JA, Harvey NC, Johansson H, Oden A, McCloskey EV, Leslie WD (2017) Overview of fracture prediction tools. J Clin Densitom 20(3):444–450CrossRef Kanis JA, Harvey NC, Johansson H, Oden A, McCloskey EV, Leslie WD (2017) Overview of fracture prediction tools. J Clin Densitom 20(3):444–450CrossRef
8.
Zurück zum Zitat Domiciano DS, Machado LG, Lopes JB, Figueiredo CP, Caparbo VF, Oliveira RM et al (2016) Bone mineral density and parathyroid hormone as independent risk factors for mortality in community-dwelling older adults: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing & Health (SPAH) Study. J Bone Miner Res 31(6):1146–1157CrossRef Domiciano DS, Machado LG, Lopes JB, Figueiredo CP, Caparbo VF, Oliveira RM et al (2016) Bone mineral density and parathyroid hormone as independent risk factors for mortality in community-dwelling older adults: a population-based prospective cohort study in Brazil. The Sao Paulo Ageing & Health (SPAH) Study. J Bone Miner Res 31(6):1146–1157CrossRef
9.
Zurück zum Zitat Johansson H, Oden A, Kanis J, McCloskey E, Lorentzon M, Ljunggren O et al (2011) Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos Int 22(5):1411–1418CrossRef Johansson H, Oden A, Kanis J, McCloskey E, Lorentzon M, Ljunggren O et al (2011) Low bone mineral density is associated with increased mortality in elderly men: MrOS Sweden. Osteoporos Int 22(5):1411–1418CrossRef
10.
Zurück zum Zitat Suzuki T, Yoshida H (2010) Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int 21(1):71–79CrossRef Suzuki T, Yoshida H (2010) Low bone mineral density at femoral neck is a predictor of increased mortality in elderly Japanese women. Osteoporos Int 21(1):71–79CrossRef
11.
Zurück zum Zitat Nguyen ND, Center JR, Eisman JA, Nguyen TV (2007) Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women. J Bone Miner Res 22(8):1147–1154CrossRef Nguyen ND, Center JR, Eisman JA, Nguyen TV (2007) Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women. J Bone Miner Res 22(8):1147–1154CrossRef
12.
Zurück zum Zitat Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR (2000) Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15(10):1974–1980CrossRef Kado DM, Browner WS, Blackwell T, Gore R, Cummings SR (2000) Rate of bone loss is associated with mortality in older women: a prospective study. J Bone Miner Res 15(10):1974–1980CrossRef
13.
Zurück zum Zitat Rodriguez AJ, Scott D, Ebeling PR (2019) Exploring the links between common diseases of ageing—osteoporosis, sarcopenia and vascular calcification. Clin Rev Bone Miner Metab 17(1):1–23CrossRef Rodriguez AJ, Scott D, Ebeling PR (2019) Exploring the links between common diseases of ageing—osteoporosis, sarcopenia and vascular calcification. Clin Rev Bone Miner Metab 17(1):1–23CrossRef
14.
Zurück zum Zitat Ahmadi N, Mao SS, Hajsadeghi F, Arnold B, Kiramijyan S, Gao Y et al (2018) The relation of low levels of bone mineral density with coronary artery calcium and mortality. Osteoporos Int 29(7):1609–1616CrossRef Ahmadi N, Mao SS, Hajsadeghi F, Arnold B, Kiramijyan S, Gao Y et al (2018) The relation of low levels of bone mineral density with coronary artery calcium and mortality. Osteoporos Int 29(7):1609–1616CrossRef
15.
Zurück zum Zitat Qu X, Huang X, Jin F, Wang H, Hao Y, Tang T et al (2013) Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 166(2):385–393CrossRef Qu X, Huang X, Jin F, Wang H, Hao Y, Tang T et al (2013) Bone mineral density and all-cause, cardiovascular and stroke mortality: a meta-analysis of prospective cohort studies. Int J Cardiol 166(2):385–393CrossRef
16.
Zurück zum Zitat Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef Lyles KW, Colon-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C et al (2007) Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med 357(18):1799–1809CrossRef
17.
Zurück zum Zitat Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P et al (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25(1):91–97CrossRef Colon-Emeric CS, Mesenbrink P, Lyles KW, Pieper CF, Boonen S, Delmas P et al (2010) Potential mediators of the mortality reduction with zoledronic acid after hip fracture. J Bone Miner Res 25(1):91–97CrossRef
18.
Zurück zum Zitat Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95(3):1174–1181CrossRef Bolland MJ, Grey AB, Gamble GD, Reid IR (2010) Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab 95(3):1174–1181CrossRef
19.
Zurück zum Zitat Peng J, Liu Y, Chen L, Peng K, Xu Z, Zhang D et al (2016) Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis. Pak J Med Sci 32(2):499–504PubMedPubMedCentral Peng J, Liu Y, Chen L, Peng K, Xu Z, Zhang D et al (2016) Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis. Pak J Med Sci 32(2):499–504PubMedPubMedCentral
20.
Zurück zum Zitat Kranenburg G, Bartstra JW, Weijmans M, de Jong PA, Mali WP, Verhaar HJ et al (2016) Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis. Atherosclerosis. 252:106–115CrossRef Kranenburg G, Bartstra JW, Weijmans M, de Jong PA, Mali WP, Verhaar HJ et al (2016) Bisphosphonates for cardiovascular risk reduction: a systematic review and meta-analysis. Atherosclerosis. 252:106–115CrossRef
21.
Zurück zum Zitat Beaupre LA, Morrish DW, Hanley DA, Maksymowych WP, Bell NR, Juby AG et al (2011) Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int 22(3):983–991CrossRef Beaupre LA, Morrish DW, Hanley DA, Maksymowych WP, Bell NR, Juby AG et al (2011) Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int 22(3):983–991CrossRef
22.
Zurück zum Zitat Bergman J, Nordström A, Hommel A, Kivipelto M, Nordström P. Bisphosphonates and mortality: confounding in observational studies? Osteoporos Int. 2019;in press. Bergman J, Nordström A, Hommel A, Kivipelto M, Nordström P. Bisphosphonates and mortality: confounding in observational studies? Osteoporos Int. 2019;in press.
23.
Zurück zum Zitat Cummings SR, Lui LY, Eastell R, Allen IE (2019) Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern Med Cummings SR, Lui LY, Eastell R, Allen IE (2019) Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis. JAMA Intern Med
24.
Zurück zum Zitat Jha S, Wang Z, Laucis N, Bhattacharyya T (2015) Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res 30(12):2179–2187CrossRef Jha S, Wang Z, Laucis N, Bhattacharyya T (2015) Trends in media reports, oral bisphosphonate prescriptions, and hip fractures 1996-2012: an ecological analysis. J Bone Miner Res 30(12):2179–2187CrossRef
25.
Zurück zum Zitat Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG et al (2016) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res Khosla S, Cauley JA, Compston J, Kiel DP, Rosen C, Saag KG et al (2016) Addressing the crisis in the treatment of osteoporosis: a path forward. J Bone Miner Res
Metadaten
Titel
Bisphosphonates and lower mortality risk: when it sounds to be good to be true …
verfasst von
W. D. Leslie
Publikationsdatum
19.10.2019
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 12/2019
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-019-05157-6

Weitere Artikel der Ausgabe 12/2019

Osteoporosis International 12/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.